| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,033 |
5,924 |
$460K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,736 |
6,563 |
$209K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,539 |
5,324 |
$205K |
| 80053 |
Comprehensive metabolic panel |
3,719 |
3,372 |
$184K |
| 36415 |
Collection of venous blood by venipuncture |
14,712 |
12,357 |
$174K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,493 |
1,441 |
$66K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
381 |
323 |
$34K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
952 |
925 |
$27K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
245 |
232 |
$26K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
204 |
193 |
$25K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
220 |
207 |
$24K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
506 |
436 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
258 |
214 |
$8K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
151 |
125 |
$7K |
| 95117 |
|
1,142 |
470 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
88 |
82 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
156 |
140 |
$5K |
| 87807 |
|
167 |
153 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
30 |
28 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
55 |
51 |
$3K |
| 87480 |
|
36 |
36 |
$3K |
| 81002 |
|
197 |
166 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
196 |
179 |
$2K |
| 87660 |
|
36 |
36 |
$2K |
| 87510 |
|
36 |
36 |
$2K |
| 85018 |
|
40 |
40 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
25 |
24 |
$994.50 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13 |
12 |
$857.70 |
| 81003 |
|
32 |
26 |
$787.34 |
| 83655 |
|
27 |
27 |
$618.29 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
36 |
30 |
$446.33 |
| 80061 |
Lipid panel |
12 |
12 |
$388.76 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14 |
12 |
$375.58 |
| 86308 |
|
13 |
12 |
$304.64 |
| J2704 |
Injection, propofol, 10 mg |
16 |
12 |
$287.98 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
29 |
27 |
$286.72 |
| 86850 |
|
12 |
12 |
$275.86 |
| 81001 |
|
15 |
12 |
$254.04 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
39 |
38 |
$237.71 |
| 86900 |
|
12 |
12 |
$236.00 |
| 86901 |
|
12 |
12 |
$236.00 |